Discover trends, market shifts, and competitive outlooks for the lupus nephritis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Lupus Nephritis Market From 2025 To 2029?

Over the last few years, the lupus nephritis market has seen significant growth. Its size is expected to expand from $1.94 billion in 2024 to $2.09 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.9%. The expansion during the past period can be associated with factors such as increased investment in lupus nephritis research, a surge in the occurrence of autoimmune diseases, rising healthcare expenses, increased use of biologics, and the growing trend of telemedicine.

Expectations are high for a strong surge in the market size of lupus nephritis in the coming years. Predictions suggest growth to $2.80 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. This growth in the forecasted period may be due to an increased awareness among physicians, a rise in the adoption rate of biologic therapies, a growing number of specialty clinics, a heightened emphasis on renal transplantation, and better accessibility to nephrology services. Key trends anticipated during this forecast period are progress in biologic therapies, customized medicine techniques, new diagnostic biomarkers, extension of clinical trials and advancements in stem cell therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Lupus Nephritis Market?

The uptick in instances of genetic predisposition is anticipated to boost the expansion of the lupus nephritis market in the future. Genetic predisposition implies the presence of inherited genetic characteristics in a person that heightens their chances of contracting specific illnesses or ailments. The rise in genetic predisposition cases can be attributed to aspects such as heredity, environmental impacts, and alterations in particular genes. The growing cases of genetic predisposition contribute significantly to the onset of lupus nephritis, underscoring the influence of hereditary genetic factors on autoimmune disorders, particularly those impairing kidney functions. For example, the UK CF Registry, managed by the Cystic Fibrosis Trust, a national charity based in the UK, reported 11,148 registered patients in 2022, which rose to 11,318 in 2024, translating to a 1.52% surge in people with cystic fibrosis (CF). Consequently, the rising cases of genetic predisposition are propelling the growth of the lupus nephritis market.

Which Key Market Segments Comprise the Lupus Nephritis Market and Drive Its Revenue Growth?

The lupus nephritis market covered in this report is segmented –

1) By Stage: Class 1, Class 2, Class 3, Other Stages

2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs

3) Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis.

2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition.

3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation.

4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22044&type=smp

Which Areas Are Leading Regions in the Lupus Nephritis Market Expansion Across the Globe?

Asia-Pacific was the largest region in the lupus nephritis market in 2024. The regions covered in the lupus nephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theLupus Nephritis Market Direction?

Major companies operating in the market of lupus nephritis are striving to develop advanced second-generation calcineurin inhibitors. The aim is to improve treatment proficiency and enhance long-term kidney results for patients. These inhibitors are employed in treating lupus nephritis as they decrease inflammation and prevent renal damage by altering immune reactions. As an illustration, in September 2024, Aurinia Pharmaceuticals Inc., a Canada-based commercial-stage biopharmaceutical firm, announced the approval of LUPKYNIS (voclosporin) by the Japanese Ministry of Health, Labour, and Welfare for the treatment of lupus nephritis. The approval enables the use of voclosporin in combination with mycophenolate mofetil (MMF), supported by data from the AURORA Clinical Program, which proved its safety and effectiveness. This approval is an important step in broadening the treatment choices for lupus nephritis patients in Japan, enhancing disease control and results.

View the full report here:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

How Is the Lupus Nephritis Market Conceptually Defined?

Lupus nephritis is a serious kidney condition caused by systemic lupus erythematosus (SLE), an autoimmune disease in which the body’s immune system mistakenly attacks healthy tissues, including the kidneys. This inflammation can lead to kidney damage, impaired function, and, if left untreated, potentially kidney failure, making early diagnosis and treatment crucial for managing the disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22044

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model